Bacterial Infections  >>  gepotidacin (GSK2140944)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gepotidacin (GSK2140944) / GSK
NCT02045797: Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

Completed
2
126
US
GSK2140944 Lyophile, GSK2140944 Capsules
GlaxoSmithKline
Infections, Bacterial
06/15
06/15
NCT02294682: A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae

Completed
2
106
US, Europe
GSK2140944
GlaxoSmithKline
Gonorrhea
07/16
07/16

Download Options